MedTrace Logo

QDOT Based PVI for Atrial Fibrillation Treatment - The peQasus Study

NCT05710822 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2023-02-02

No results posted yet for this study

Summary

PeQasus is a worldwide, retrospective, multicenter analysis focusing on QDOT based PVI. Data of at least 300 patients with QDOT based PVI will be collected. All data will be evaluated after anonymization. Primary endoints are efficacy and safety.

Conditions

Interventions

DEVICE

pulmonary vein isolation

pulmonary vein isolation utilizing the QDOT Micro ablation catheter

Sponsors & Collaborators

  • University of Luebeck

    lead OTHER

Principal Investigators

  • Christian-Hendrik Heeger, MD · Department of Rhythmology

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-01-31
Primary Completion
2023-06-30
Completion
2023-06-30

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05710822 on ClinicalTrials.gov